|
Have Your Say Rate this feature and give us your feedback in the comments section below |
Pharmaceuticals & Biotechnology Editor | 01/08/2013
With budgets being cut and margins becoming tighter, PAT and Quality by Design are becoming more and more critical for the pharmaceutical industry. In a recent survey carried out by Pharma IQ, 80% said they plan to invest in PAT and QbD solutions. In preparation for the 10th Annual PAT and QbD conference, Pharma IQ has analysed the change in investment levels over the last 3 years and presents the results in this infographic.
For more information about the 10th Anniversary PAT and Quality by Design event, go to www.patandqbd.com
RECOMMENDED
Pharma Contract Manufacturing 2025
2025-03-03
Digital Transformation in Pharma: Navigating CMO Partnerships and Supply Chain Resilience
2025-01-22
Upcoming Events
AI for Pharma & Healthcare
23 - 25 September, 2025
Amsterdam
Register Now |
View Agenda |
Learn More